Key models for drug development in systemic sclerosis
Systemic sclerosis (SSc), also known as scleroderma, is a systemic autoimmune disease characterized by limited or diffuse skin thickening and fibrosis. The lesions are characterized by cutaneous fibroplasia and vascular onion skin-like changes, which eventually lead to skin sclerosis and vascular ischemia.We have established a stable model of bleomycin (BLM)-induced systemic sclerosis, which is suitable for preclinical systemic sclerosis drug research and new drug evaluation.
If you have a project need and experience more of our professional services, please contact us.
Our services
Model classification | Model Name | Animal species |
Systemic sclerosis | Bleomycin (BLM)-induced model of systemic sclerosis | Mice |